12
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Estrategia de abastecimiento colaborativo para el sector salud derivado de un estudio clínico de Covid-19 Translated title: Collaborative sourcing for the health sector derived from a Covid-19 clinical trial

      research-article

      Read this article at

      SciELO
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen La logística hospitalaria comprende un conjunto de actividades asociadas al proceso de aprovisionamiento, almacenamiento y distribución de medicamentos y demás insumos necesarios para el manejo clínico de pacientes. Este trabajo presenta el diseño de una estrategia de abastecimiento colaborativo de medicamentos que permite la realización de un estudio clínico de Covid-19, minimizando interrupciones, costos y tiempos de suministro. Este trabajo se realizó en tres fases: en la primera se llevó a cabo un análisis del contexto y una revisión de las normas de cada una de las instituciones prestadoras de salud (IPS) participantes; en la segunda se diseñaron protocolos y manuales para los procesos de aprovisionamiento y gestión de inventarios; y en la tercera se implementaron los procesos previamente diseñados durante el desarrollo de la investigación clínica. Como resultado de este trabajo se presenta una estrategia basada en un modelo colaborativo de gestión de compras e inventarios, compuesto por tres laboratorios de productos farmacéuticos, un centro de mezclas y diez IPS. Además, se diseñaron procesos para la gestión y trazabilidad de inventarios de forma colaborativa. En última instancia, estos resultados pueden ser utilizados para evaluar la coordinación de toda la cadena de suministro hospitalaria (CSH) en un escenario de pandemia.

          Translated abstract

          Abstract Hospital logistics encompasses a range of activities related to the procurement, storage, and distribution of medications and other supplies required for the clinical care of patients. This work presents the design of a collaborative medication supply strategy that allows for the conduct of a COViD-19 clinical tiral, minimizing interruptions, costs, and supply times. This work was carried out in three phases: in the first phase, a context analysis was carried out and a review of the rules of each of the participating health care providers was conducted; in the second phase, protocols and manuals were designed for procurement and inventory management processes; and in the third phase, finally, the previously designed processes were implemented during the clinical trial. As a result of this work, a strategy based on a collaborative purchasing and inventory management model is presented, consisting of three pharmaceutical product laboratories, a mixing center, and ten healthcare providers. In addition, processes were designed for the collaborative management and traceability of inventory. Ultimately, these results can be used to evaluate the coordination of the entire hospital supply chain (HSC) in a pandemic scenario.

          Related collections

          Most cited references46

          • Record: found
          • Abstract: found
          • Book: not found

          Designing and Conducting Mixed Methods Research

          Combining the latest thinking in the field with practical, step-by-step guidance, the Third Edition of John W. Creswell and Vicki L. Plano Clark’s Designing and Conducting Mixed Methods Research now covers seven mixed methods designs with accompanying journal articles illustrating each design. The authors walk readers through the entire research process, and present updated examples from published mixed methods studies drawn from multiple disciplines. In addition, this new edition includes information about the dynamic and evolving nature of the field of mixed methods research, four additional methodological approaches, and coverage of new directions in mixed methods.
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Clinical trials on drug repositioning for COVID-19 treatment

            ABSTRACT The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genus Betacoronavirus, that is distributed in birds, humans, and other mammals. WHO has named the novel coronavirus disease as COVID-19. More than 80 clinical trials have been launched to test coronavirus treatment, including some drug repurposing or repositioning for COVID-19. Hence, we performed a search in March 2020 of the clinicaltrials.gov database. The eligibility criteria for the retrieved studies were: contain a clinicaltrials.gov base identifier number; describe the number of participants and the period for the study; describe the participants’ clinical conditions; and utilize interventions with medicines already studied or approved for any other disease in patients infected with the novel coronavirus SARS-CoV-2 (2019-nCoV). It is essential to emphasize that this article only captured trials listed in the clinicaltrials.gov database. We identified 24 clinical trials, involving more than 20 medicines, such as human immunoglobulin, interferons, chloroquine, hydroxychloroquine, arbidol, remdesivir, favipiravir, lopinavir, ritonavir, oseltamivir, methylprednisolone, bevacizumab, and traditional Chinese medicines (TCM). Although drug repurposing has some limitations, repositioning clinical trials may represent an attractive strategy because they facilitate the discovery of new classes of medicines; they have lower costs and take less time to reach the market; and there are existing pharmaceutical supply chains for formulation and distribution.
              • Record: found
              • Abstract: found
              • Article: not found

              A critical look at Lean Thinking in healthcare.

              With healthcare, Lean Thinking encounters a world, not devoid of value, but awash with sophisticated and mutually unconnected concepts of value. Given a shortage of systematic analysis in the literature, this paper provides a preliminary analysis of areas where the read-across from other sectors to healthcare is relatively well understood, based on a broad review of its impact on care delivery. It further proposes areas where conceptual development is needed. In particular, healthcare, with its many measures of value, presents an unusual challenge to the central Lean driver of value to the customer. We conclude that there is scope for methodological development, perhaps by defining three themes associated with value-the operational, the clinical and the experiential.

                Author and article information

                Journal
                inde
                Ingeniería y Desarrollo
                Ing. Desarro.
                Fundación Universidad del Norte (Barranquilla, Atlantico, Colombia )
                0122-3461
                2145-9371
                June 2024
                : 42
                : 1
                : 1
                Affiliations
                [1] orgnameUniversidad Nacional de Colombia orgdiv1Departamento de Ingeniería de Sistemas e Industrial Colombia erruizo@ 123456unal.edu.co
                [2] orgnameUniversidad Nacional de Colombia orgdiv1Departamento de Ingeniería de Sistemas e Industria Colombia wadarmej@ 123456unal.edu.co
                [3] orgnameUniversidad Nacional de Colombia orgdiv1Departamento de Obstetricia y Ginecología Colombia hggaitand@ 123456unal.edu.co
                Author information
                https://orcid.org/0000-0002-1047-9989
                https://orcid.org/0000-0001-7401-223X
                https://orcid.org/0000-0003-2939-3648
                Article
                S0122-34612024000100003 S0122-3461(24)04200100003
                10.14482/inde.42.01.345.555
                19c97bc1-48fe-44ae-a70f-8cde4a96823a

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 01 February 2023
                : 27 June 2023
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 49, Pages: 0
                Product

                SciELO Colombia

                Categories
                Artículo de investigación

                abastecimiento,traceability,supply,hospital logistics,Covid-19,collaborative model,clinical trial,trazabilidad,modelo colaborativo,logística hospitalaria,estudio clínico,Co-vid-19

                Comments

                Comment on this article

                Related Documents Log